Report overview
Cefuroxime Powder For Injection is used to treat certain infections caused by bacteria including pneumonia and other lower respiratory tract (lung) infections; meningitis (infection of the membranes that surround the brain and spinal cord); gonorrhea (a sexually transmitted disease); and skin, blood, bone, joint, and urinary tract infections. Cefuroxime injection may also be used before, during, and sometimes for a brief period after surgery in order to prevent the patient from getting an infection. Cefuroxime injection is in a class of medications called cephalosporin antibiotics. It works by killing bacteria.
This report aims to provide a comprehensive presentation of the global market for Cefuroxime Powder For Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cefuroxime Powder For Injection. This report contains market size and forecasts of Cefuroxime Powder For Injection in global, including the following market information:
Global Cefuroxime Powder For Injection Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global Cefuroxime Powder For Injection Market Sales, 2018-2023, 2024-2032, (Ton)
Global top five Cefuroxime Powder For Injection companies in 2022 (%)
The global Cefuroxime Powder For Injection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
250 mg Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cefuroxime Powder For Injection include GlaxoSmithKline (GSK), Flynn Pharma Ltd, Fresenius Kabi, Bowmed Ibisqus Limited, Devatis Limited, AdvaCare Pharma, Lekhim, AFT Pharmaceuticals and Biolab Co.,Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cefuroxime Powder For Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cefuroxime Powder For Injection Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (Ton)
Global Cefuroxime Powder For Injection Market Segment Percentages, by Type, 2022 (%)
250 mg
750 mg
1 g
1.5 g
Global Cefuroxime Powder For Injection Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (Ton)
Global Cefuroxime Powder For Injection Market Segment Percentages, by Application, 2022 (%)
Adult Use
Pediatric Use
Global Cefuroxime Powder For Injection Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (Ton)
Global Cefuroxime Powder For Injection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cefuroxime Powder For Injection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cefuroxime Powder For Injection revenues share in global market, 2022 (%)
Key companies Cefuroxime Powder For Injection sales in global market, 2018-2023 (Estimated), (Ton)
Key companies Cefuroxime Powder For Injection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlaxoSmithKline (GSK)
Flynn Pharma Ltd
Fresenius Kabi
Bowmed Ibisqus Limited
Devatis Limited
AdvaCare Pharma
Lekhim
AFT Pharmaceuticals
Biolab Co.,Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cefuroxime Powder For Injection, market overview.
Chapter 2: Global Cefuroxime Powder For Injection market size in revenue and volume.
Chapter 3: Detailed analysis of Cefuroxime Powder For Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cefuroxime Powder For Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cefuroxime Powder For Injection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
